{"status": "Ok", "redirect_url": "https://www.investor.jnj.com/investor-news/news-details/2026/New-TECVAYLI-teclistamab-cqyv-data-demonstrate-superior-progression-free-and-overall-survival-as-early-as-first-relapse-in-multiple-myeloma/default.aspx", "message": "News view counter 766730 successfully enlarged"}